Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa

François Lemonnier
  • Fonction : Auteur
  • PersonId : 1012278
Gabriel Brisou
Olivier Casasnovas
Emmanuel Bachy
Marc André
Romain Guièze
Sylvain Carras
Bohrane Slama
  • Fonction : Auteur
Clémentine Sarkozy
Franck Morschhauser

Dates et versions

hal-04344799 , version 1 (14-12-2023)

Identifiants

Citer

Loic Ysebaert, François Lemonnier, Gabriel Brisou, Olivier Casasnovas, Gian Matteo Pica, et al.. Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa. 65th ASH Annual Meeting, Dec 2023, San Diego, United States. pp.297, ⟨10.1182/blood-2023-185057⟩. ⟨hal-04344799⟩
31 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More